Undisclosed CDH17/HER3 bispecific ADC
/ Biocytogen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
A Novel CDH17/HER3 Bispecific ADC Demonstrates Superior Preclinical Efficacy in Colorectal Cancer
(SITC 2026)
- No abstract available
ADC • Bispecific • Preclinical • Colorectal Cancer • Oncology • Solid Tumor • CDH17 • ERBB3
1 to 1
Of
1
Go to page
1